(Q28138868)

GOA release 2020-03-11

1 reference

0 references

M D Hulett

1

0 references

C Freeman

2

0 references

B J Hamdorf

3

0 references

R T Baker

4

0 references

M J Harris

5

0 references

C R Parish

Structural differences of heparan sulfates according to the tissue and species of origin

6

0 references

language of work or name

English

0 references

publication date

July 1999

0 references

published in

Nature Medicine

0 references

volume

5

0 references

issue

7

0 references

page(s)

803-9

0 references

cites work

1 reference

7 January 2021

Proteoglycans: structures and interactions

1 reference

7 January 2021

CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes

1 reference

7 January 2021

Human platelet heparanase: purification, characterization and catalytic activity

1 reference

7 January 2021

Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes

1 reference

7 January 2021

Human mononuclear cells contain an endoglycosidase specific for heparan sulphate glycosaminoglycan demonstrable with the use of a specific solid-phase metabolically radiolabelled substrate

1 reference

7 January 2021

Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase

1 reference

7 January 2021

Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase

1 reference

7 January 2021

Heparanase activity in cultured endothelial cells

1 reference

7 January 2021

A rapid quantitative assay for the detection of mammalian heparanase activity

1 reference

7 January 2021

Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines

1 reference

7 January 2021

Growth factors in the extracellular matrix

1 reference

7 January 2021

Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix

1 reference

7 January 2021

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

1 reference

7 January 2021

Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype

1 reference

7 January 2021

Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts

1 reference

7 January 2021

Substrate specificity of heparanases from human hepatoma and platelets

1 reference

7 January 2021

Immunoselection of GRP94/endoplasmin from a KNRK cell-specific lambda gt11 library using antibodies directed against a putative heparanase amino-terminal peptide

1 reference

7 January 2021

Tumour rejection antigens of the hsp90 family (gp96) closely resemble tumour-associated heparanase enzymes

1 reference

7 January 2021

A cellulose-binding domain-fused recombinant human T cell connective tissue-activating peptide-III manifests heparanase activity

1 reference

7 January 2021

Partial sequence of human platelet heparitinase and evidence of its ability to polymerize

1 reference

7 January 2021

Production of heparanase by normal and neoplastic murine B-lymphocytes

1 reference

7 January 2021

Heparanases and tumor metastasis

1 reference

7 January 2021

A comparative analysis of the primary sequences and characteristics of heparinases I, II, and III from Flavobacterium heparinum

1 reference

7 January 2021

Substrate specificity of the heparin lyases from Flavobacterium heparinum

1 reference

7 January 2021

Enzymatic degradation of glycosaminoglycans

1 reference

7 January 2021

Treatment of central nervous system inflammation with inhibitors of basement membrane degradation.

1 reference

7 January 2021

Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity

1 reference

7 January 2021

Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins

1 reference

7 January 2021

Improvement of an "In-Gel" digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing

1 reference

7 January 2021

Lactose synthesis in a monotreme, the echidna (Tachyglossus aculeatus): isolation and amino acid sequence of echidna alpha-lactalbumin

1 reference

7 January 2021

A basement-membrane permeability assay which correlates with the metastatic potential of tumour cells

1 reference

7 January 2021

Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension

1 reference

7 January 2021

Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure

1 reference

7 January 2021

Identifiers

DOI

10.1038/10525

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

10395326

1 reference

Consolidated OpenCitations Corpus – April 2017